Keywords: Merck & Co, Vertex, Victrelis, Telaprivir, USA, FDA, Johnson & Johnson

Merck & Co’s Victrelis and Vertex’ telaprivir get unanimous backing from FDA advisory panel for chronic hep C

Article | 29 April 2011

Print This

The Antiviral Drugs Advisory Committee of the US Food and Drug Administration has voted unanimously that the available data support ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in